MREO
Mereo BioPharma Group plc
NASDAQ · Healthcare · Biotechnology · GB
$0.25
−8.16%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-17.2%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Feb 27, 2026 | Bender Jeremy · director | A-Award | 66,000 | $0.39 |
| Feb 27, 2026 | Jenkins Annalisa · director | A-Award | 106,848 | $0.00 |
| Feb 27, 2026 | WYZGA MICHAEL S · director | A-Award | 66,000 | $0.39 |
| Feb 27, 2026 | Jenkins Annalisa · director | A-Award | 66,000 | $0.39 |
| Feb 27, 2026 | Ekblom Anders · director | A-Award | 133,560 | $0.00 |
| Feb 27, 2026 | Ekblom Anders · director | A-Award | 66,000 | $0.39 |
| Feb 27, 2026 | Shames Daniel · director | A-Award | 96,163 | $0.00 |
| Feb 27, 2026 | Shames Daniel · director | A-Award | 66,000 | $0.39 |
| Feb 27, 2026 | Yoskowitz Marc J · director | A-Award | 96,163 | $0.00 |
| Feb 27, 2026 | Yoskowitz Marc J · director | A-Award | 66,000 | $0.39 |
| Feb 27, 2026 | Jacquet Pierre · director | A-Award | 106,848 | $0.00 |
| Feb 27, 2026 | Jacquet Pierre · director | A-Award | 66,000 | $0.39 |
| Feb 27, 2026 | PAKIANATHAN DEEPIKA · director | A-Award | 66,000 | $0.39 |
| Feb 27, 2026 | Bender Jeremy · director | A-Award | 117,533 | $0.00 |
| Feb 2, 2026 | Sermon Charles · officer: General Counsel | A-Award | 315,750 | $0.44 |
| Feb 2, 2026 | Fox Christine Ann · officer: Chief Financial Officer | A-Award | 315,750 | $0.44 |
| Feb 2, 2026 | Fox Christine Ann · officer: Chief Financial Officer | A-Award | 280,000 | $0.44 |
| Feb 2, 2026 | Fox Christine Ann · officer: Chief Financial Officer | A-Award | 105,250 | $1.00 |
| Feb 2, 2026 | Lewicki John A. · officer: Chief Scientific Officer | A-Award | 139,913 | $0.44 |
| Feb 2, 2026 | Lewicki John A. · officer: Chief Scientific Officer | A-Award | 46,637 | $1.00 |
| Feb 2, 2026 | Hughes-Wilson Alexandra · officer: See Remarks | A-Award | 195,000 | $0.44 |
| Feb 2, 2026 | Hughes-Wilson Alexandra · officer: See Remarks | A-Award | 183,750 | $0.44 |
| Feb 2, 2026 | Hughes-Wilson Alexandra · officer: See Remarks | A-Award | 61,250 | $1.00 |
| Feb 2, 2026 | Sermon Charles · officer: General Counsel | A-Award | 295,000 | $0.44 |
| Feb 2, 2026 | Sermon Charles · officer: General Counsel | A-Award | 105,250 | $1.00 |
| Feb 2, 2026 | Lewicki John A. · officer: Chief Scientific Officer | A-Award | 145,000 | $0.44 |
| Feb 2, 2026 | Scots-Knight Denise · director, officer: Chief Executive Officer | A-Award | 1,035,000 | $0.44 |
| Feb 2, 2026 | Scots-Knight Denise · director, officer: Chief Executive Officer | A-Award | 480,000 | $0.44 |
| Feb 2, 2026 | Scots-Knight Denise · director, officer: Chief Executive Officer | A-Award | 345,000 | $1.00 |
| Feb 6, 2025 | Jacquet Pierre · director | A-Award | 15,243 | $0.00 |
Institutional positioning
13F filings over the trailing two quarters
New 14Increased 16Reduced 21Sold out 64
| Filer | Action | Shares | Filed |
|---|---|---|---|
| RUBRIC CAPITAL MANAGEMENT LP | Unchanged | 15,307,347 | May 15, 2026 |
| ECOR1 CAPITAL, LLC | Increased | 13,368,855 | May 15, 2026 |
| 683 CAPITAL MANAGEMENT, LLC | Reduced | 12,000,000 | May 15, 2026 |
| BANK OF AMERICA CORP /DE/ | Increased | 8,195,287 | May 18, 2026 |
| Defilade Capital Management, L.P. | New Position | 7,558,756 | Jun 12, 2026 |
| NEWTYN MANAGEMENT, LLC | Increased | 7,079,056 | May 15, 2026 |
| MILLENNIUM MANAGEMENT LLC | Increased | 3,559,103 | May 15, 2026 |
| TEJARA CAPITAL LTD | Reduced | 2,037,520 | May 12, 2026 |
| UBS GROUP AG | Reduced | 1,490,128 | May 5, 2026 |
| CITADEL ADVISORS LLC | Increased | 1,000,058 | Sep 2, 2026 |
| WEALTHSPIRE ADVISORS, LLC | New Position | 796,036 | May 1, 2026 |
| MARSHALL WACE, LLP | New Position | 686,987 | May 15, 2026 |
| CITADEL ADVISORS LLC | Reduced | 454,800 | May 15, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | Reduced | 443,920 | May 15, 2026 |
| GROUP ONE TRADING, L.P. | Reduced | 335,827 | May 13, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Feb 27, 2026